Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Abridge adds live prior authorization to its AI scribe with Highmark Health

0 Mins
Ambient scribe company Abridge, partnering with Highmark Health, says it can give information on prior authorization during, not just after, a patient visit.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago